Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome.
about
Body composition profile of young patients with phenylketonuria and mild hyperphenylalaninemia.Analysis of body composition and nutritional status in Brazilian phenylketonuria patients.Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.Overweight and obesity in PKU: The results from 8 centres in Europe and Turkey.Recommendations for the nutrition management of phenylalanine hydroxylase deficiency.Modeling correlates of low bone mineral density in patients with phenylalanine hydroxylase deficiency.Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile.The complete European guidelines on phenylketonuria: diagnosis and treatment.Hyperphenylalaninemia Correlated with Global Decrease of Antioxidant Genes Expression in White Blood Cells of Adult Patients with Phenylketonuria.The influence of parental food preference and neophobia on children with phenylketonuria (PKU).Dietary intervention in the management of phenylketonuria: current perspectives.Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.Carbohydrate status in patients with phenylketonuria.Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis.
P2860
Q34196837-3CAF7274-1E1D-4928-8F4D-6194AE69D37BQ36680625-BC3E8C32-E4E5-4D5B-91A5-DF842CF4D4AEQ37243758-B9FFB680-31FA-4791-BA7C-3483705E033BQ37434190-B63FA01B-EC9B-4901-8A50-9B967EEC5FC1Q37570443-34FFC386-EDBA-4DA5-B33E-F76DB6C78AFAQ39992743-3923AC2E-5452-4EEE-ADEE-6A372C2D44DEQ40181778-F811872C-15B8-48A3-8147-2A055561D5D5Q42376686-6E67C8C8-1AF9-4969-B57B-E17377F3570BQ46404150-30E267E4-88F8-4D17-B434-74D5D2A6F9E0Q47156155-5A83E03D-8D90-4011-AF5C-3A950F33F554Q49500552-BC621DDF-9505-4B55-BA84-9602E96124EFQ50733179-CFF89547-C56E-476E-8B29-A772528E1BF0Q55439557-15EE3C78-307D-4D44-9AFD-116D9887AFA4Q55474071-7CD37DC5-3207-41CB-993B-097C2B65F2F7
P2860
Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Dietary treatment in phenylket ...... obesity or metabolic syndrome.
@en
Dietary treatment in phenylket ...... obesity or metabolic syndrome.
@nl
type
label
Dietary treatment in phenylket ...... obesity or metabolic syndrome.
@en
Dietary treatment in phenylket ...... obesity or metabolic syndrome.
@nl
prefLabel
Dietary treatment in phenylket ...... obesity or metabolic syndrome.
@en
Dietary treatment in phenylket ...... obesity or metabolic syndrome.
@nl
P50
P921
P1476
Dietary treatment in phenylket ...... obesity or metabolic syndrome.
@en
P2093
Francjan J van Spronsen
Gabriela Soares
P304
P356
10.1016/J.YMGME.2012.10.006
P577
2012-10-16T00:00:00Z